427 related articles for article (PubMed ID: 25524553)
21. [The Role of MicroRNAs in Colorectal Cancer].
Kim SW
Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
[TBL] [Abstract][Full Text] [Related]
22. Non-coding landscapes of colorectal cancer.
Ragusa M; Barbagallo C; Statello L; Condorelli AG; Battaglia R; Tamburello L; Barbagallo D; Di Pietro C; Purrello M
World J Gastroenterol; 2015 Nov; 21(41):11709-39. PubMed ID: 26556998
[TBL] [Abstract][Full Text] [Related]
23. MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2.
Li J; Du L; Yang Y; Wang C; Liu H; Wang L; Zhang X; Li W; Zheng G; Dong Z
Cancer Lett; 2013 Feb; 329(1):84-90. PubMed ID: 23111103
[TBL] [Abstract][Full Text] [Related]
24. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
Li X; Nie J; Mei Q; Han WD
World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
[TBL] [Abstract][Full Text] [Related]
26. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
Hibner G; Kimsa-Furdzik M; Francuz T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
[TBL] [Abstract][Full Text] [Related]
27. Emerging role of microRNA-21 in colorectal cancer.
Zhao J; Zhang Y; Zhao G
Cancer Biomark; 2015; 15(3):219-26. PubMed ID: 25769454
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.
Slaby O; Svoboda M; Michalek J; Vyzula R
Mol Cancer; 2009 Nov; 8():102. PubMed ID: 19912656
[TBL] [Abstract][Full Text] [Related]
31. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
[TBL] [Abstract][Full Text] [Related]
32. The roles of microRNA in cancer and apoptosis.
Lynam-Lennon N; Maher SG; Reynolds JV
Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
[TBL] [Abstract][Full Text] [Related]
33. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
Cheng G
Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.
Liu Y; Zhou Y; Feng X; An P; Quan X; Wang H; Ye S; Yu C; He Y; Luo H
Int J Oncol; 2014 Jan; 44(1):203-10. PubMed ID: 24189753
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
38. MiRNAs as biomarkers and therapeutic targets in cancer.
Heneghan HM; Miller N; Kerin MJ
Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
[TBL] [Abstract][Full Text] [Related]
39. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives.
Hernández R; Sánchez-Jiménez E; Melguizo C; Prados J; Rama AR
BMB Rep; 2018 Nov; 51(11):563-571. PubMed ID: 30158023
[TBL] [Abstract][Full Text] [Related]
40. The role of miRNAs in colorectal cancer progression and chemoradiotherapy.
Zhang N; Hu X; Du Y; Du J
Biomed Pharmacother; 2021 Feb; 134():111099. PubMed ID: 33338745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
